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D
ue to their extremely small size, air-
borne engineered nanomaterials
(ENMs) can reach the deepest por-
tions of the lung when inhaled and poten-
tially move into systemic circulation.1 One
such ENM2 is the carbon nanotube (CNT),
which is highly marketable because of its
unusual tensile strength, thermal conductivity,
electrical properties, and broad commercial
applications. Of particular concern, CNTs have
similar properties to disease-causing asbestos
fibers (e.g., highaspect ratio, large surfacearea,
and poor solubility). Toxicology studies using
rats and mice have shown that exposure to
multiwalled carbon nanotubes (MWCNTs) re-
sulted in not only pulmonary inflammation
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ABSTRACT Inhaled multiwalled carbon nanotubes (MWCNTs)
may cause adverse pulmonary responses due to their nanoscale,
fibrous morphology and/or biopersistance. This study tested multiple
factors (dose, time, physicochemical characteristics, and administra-
tionmethod) shown to affect MWCNT toxicity with the hypothesis that
these factors will influence significantly different responses upon
MWCNT exposure. The study is unique in that (1) multiple adminis-
tration methods were tested using particles from the same stock; (2)
bulk MWCNT formulations had few differences (metal content, surface area/functionalization); and (3) MWCNT retention was quantified using a specialized
approach for measuring unlabeled MWCNTs in rodent lungs. Male SpragueDawley rats were exposed to original (O), purified (P), and carboxylic acid
functionalized (F) MWCNTs via intratracheal instillation and inhalation. Blood, bronchoalveolar lavage fluid (BALF), and lung tissues were collected at
postexposure days 1 and 21 for quantifying biological responses and MWCNTs in lung tissues by programmed thermal analysis. At day 1, MWCNT instillation
produced significant BALF neutrophilia and MWCNT-positive macrophages. Instilled O- and P-MWCNTs produced significant inflammation in lung tissues, which
resolved by day 21 despite MWCNT retention. MWCNT inhalation produced no BALF neutrophilia and no significant histopathology past day 1. However, on days
1 and 21 postinhalation of nebulized MWCNTs, significantly increased numbers of MWCNT-positive macrophages were observed in BALF. Results suggest (1)
MWCNTs produce transient inflammation if any despite persistence in the lungs; (2) instilled O-MWCNTs cause more inflammation than P- or F-MWCNTs; and (3)
MWCNT suspension media produce strikingly different effects on physicochemical particle characteristics and pulmonary responses.
KEYWORDS: pulmonary toxicity . inflammation . engineered nanomaterial . inhalation exposure .
multiwalled carbon nanotube (MWCNT)
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and fibrosis3 but also cancerous lesions consis-
tent with mesothelioma.4 This may be the result of
MWCNTs eliciting frustrated phagocytosis in exposed
cells.5,6 In this process, phagocytic cells fail to fully
engulf target particles and instead release their
internal degradative enzymes into the interstitium,
causing damage to nearby host cells, inflammation,
and, over time, fibrotic lesions. MWCNTs are currently
being produced on a grand scale (>4000 t/year
worldwide)7 and sold at a significantly lower price
than the single-walled variety (SWCNTs). Because
MWCNTs are expected to be biopersistent,8,9 as
more particles enter the ecosystem, the risk of exposure
could increase over time.
Due to the disproportionate lack of in vivo studies
and the vast heterogeneity of MWCNTs, investigations
into specific administrationmethods and CNT formula-
tions are needed to better understand the parameters
that best correlate to human compatibility/toxicity in
the animal model. To be specific, few studies have
investigated the relationships among (a) MWCNT tox-
icity in vivo (dose and recovery over time), (b) admin-
istration techniques [e.g., intratracheal instillation (IT)
vs inhalation], and (c) particle physicochemical char-
acteristics (e.g., metal content and hydrophilicity) alto-
gether. Fewer have actually quantified the clearance of
different MWCNTs in tissues postexposure.10,11 This
study is one of few to take a comprehensive, holistic
approach to evaluating and quantifying responses
postexposure to MWCNTs. Main factors (dose, time,
physicochemical characteristics, and administration
method) shown separately in previous publications
to affect MWCNT retention and/or toxic responses
in vivo and/or in vitro were considered, and MWCNT
formulations from the same batch were used to
compare/contrast findings. By considering all the
aforementioned factors and controlling the MWCNT
variability, confounders that can influence differential
findings across laboratories and/or across studies with-
in the same laboratory were eliminated. This study is
also one of the few to quantify unlabeled MWCNTs in
exposed animal tissues and the only to quantify un-
labeled F-MWCNTs using programmed thermal anal-
ysis (PTA). Because of their organic nature,MWCNTs are
rarely ever quantified in tissues postexposure, and this
is one reason that pharmacokinetic data are sorely
missing in the literature (especially with respect to
unlabeled MWCNTs).
We aimed to determine how the particular factors of
dose, time, physicochemical characteristics, and ad-
ministration method modulate pulmonary inflamma-
tion, cellular injury, and particle clearance/retention in
SpragueDawley (SD) rats after exposure to various
formulations of engineered MWCNTs. Three formula-
tions of MWCNTs were tested by IT: original (O),
purified (P), and carboxylic acid functionalized (F).
To determine the doseresponse effect, rats were
instilled with MWCNTs (0, 10, 50, or 200 μg) suspended
in a biocompatible dispersion media (DM).12
In separate experiments, animals were exposed
via inhalation for a single 6 h period (approximating
the 200 μg instilled dose) to O-, P-, or F-MWCNTs in DM,
or to F-MWCNTs in water. Inhalation studies with
F-MWCNTs in water were completed first because
F-MWCNTs are readily dispersed in water for neb-
ulization and show promise for use in thin films13
and nanopesticides,14 which are often applied
as spray coatings. F-MWCNTs are also being studied
for use in hydrogels for tissue engineering and/or
drug delivery,15 and other medical applications,16
wherein O- and/or P-MWCNTs cannot be used due
to either possible inherent toxicity and/or instability
in aqueous suspensions. Nebulization of F-MWCNTs
in water also enabled observation of postexpo-
sure biological responses uninfluenced by DM
and thus a better approximation of occupational
exposures.
Inhalation studies with MWCNTs suspended in DM
were completed next for direct comparison to the
instillation studies. The DM provides equivalent dis-
persion of engineered nanomaterials to bronchoalveo-
lar lavage fluid (BALF) and stabilizes hydrophobic
particles (like O- and P-MWCNTs) to decrease clumping
and settling in suspension, but DM alone avoids added
toxicity. Without added functional groups to sterically
hinder O- and P-MWCNT agglomeration, bundles/
aggregates and precipitation are more likely in the
absence of DM.
For all studies, blood and BALF was collected at 1 or
21 days postexposure to assess lung total and differ-
ential cell counts, lactate dehydrogenase (LDH), and
total protein for signs of inflammation, cell membrane
damage, and lung permeability, as these analyses are
common, relatively easy, and inexpensive to complete.
MWCNT-laden macrophages (Mj) were also quanti-
fied in BALF and imaged by transmission electron
microscopy (TEM). Blood was collected to assess
changes in complete blood count (CBC), and body
weights were taken to assess potential systemic ef-
fects. Finally, lung tissues were collected to quantify
particle retention and/or evaluate histopathological
abnormalities such as increased cellular infiltrates,
mucus production, and fibrosis.
RESULTS AND DISCUSSION
Combining expertise in the fields of toxicology,
molecular biology, engineering, chemistry, occupa-
tional exposure, and environmental sciences, the study
described here tested multiple factors (dose, time,
physicochemical characteristics, and administration
method) shown previously to affect MWCNT toxicity
in vivo and/or in vitro. Although there aremerits to their
respective methodologies, many in vivo MWCNT stud-
ies to date compare particles with many inherent
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differences and/or do not provide dosimetric measure-
ments when correlating pulmonary toxicity and parti-
cle exposure. In fact, analytical quantification of
MWCNTs in tissues is rarely done due to the diffi-
culty in distinguishing the xenobiotic MWCNTs from
eobiotic carbonaceous species in exposed biological
matrices. Further, although the efficacy of high-
throughput in vitro assays cannot be denied with
respect to initial screening of potentially toxic ENMs,
these studies often overlook the effects of the bio-
logical milieu and, therefore, should be succeeded by
in vivo assessments. This study is unique in that (1) the
IT dose range approximates doses equivalent to
1 week, 5 weeks, and 5 months in an occupational
setting; (2) multiple administration methods were
tested using particles from the same stock; (3) the
different bulk MWCNT forms used had only a few,
clearly defined differences (metal content, surface
area, surface functionalization), making spurious cor-
relations less likely; and (4) MWCNTs were quantified
using a relatively new, specialized approach10,17 aimed
at measuring various forms of unlabeled MWCNTs in
rodent lungs. Previous studies have obtained prelimin-
ary hazard rankings for the MWCNTs tested here.3,18
Results from experiments aimed at expanding the
knowledge of these MWCNT behaviors in vivo form
the basis of this study.
Physicochemical Particle Characteristics. Bulk MWCNTs
had typically high aspect ratios, a range of morpholo-
gies from straight to curled often appearing in tangled
agglomerates, and no visible tube damage resulting
from either purification or functionalization (Figure 1).
O-MWCNTs had 4.49% and 0.76% of Ni and Fe residual
catalyst, respectively, whichwas determined by energy
dispersive X-ray spectroscopy (EDS) and confirmed
by inductively coupled plasma mass spectrometry
(ICP-MS).26 The same catalysts dropped to 1.8% and
0.08%, respectively, for P-MWCNTs and to nondetect-
able values for F-MWCNTs. Zeta potential measure-
ments in water for O-, P-, and F-MWCNT were 14.5,
8.3, and 50.5, respectively, indicating high disper-
sibility for F-MWCNTs and unstable behavior for O- and
P-MWCNTs at neutral pH. These values are similar to
those reported previously for analogous CNTs.26,35,36
BrunauerEmmettTeller (BET) analysis of O-, P-, and
F-MWCNTs showed surface areas of 182, 168, and
224 m2/g, respectively. According to Birch and
colleagues,19 metal content, amorphous carbon impu-
rities, acid purification, and surface functionalization
all influence CNT surface area measurements by BET.
Additional details on the physicochemical character-
ization of the MWCNTs have been presented else-
where.26,36
MWCNT Preparations for DoseResponse Instillation Studies.
Suspension and probe sonication of MWCNTs in DM
produced well-dispersed instillates in comparison to
water. Although the primary length was 1030 μm for
all MWCNTs in dry bulk form, the hydrodynamic size
of O-, P-, and F-MWCNTs in DM was generally less than
1 μm in length.
Aerosol Characterization: F-MWCNTs in Water. Gravimetric
analyses showed that field blanks were clean. Over the
course of the 6 h exposure to F-MWCNTs in water,
cascade impactor samples showed concentrations
averaged approximately 30 mg/m3. At this concentra-
tion, rats would have inhaled approximately 1.62mg of
F-MWCNTs during the 6 h period assuming they had a
ventilation rate (V) = 0.15 L/min. Deposition is esti-
mated to be at most 14%,20 which would suggest a
maximum of approximately 227 μg of F-MWCNTs was
deposited in the tracheobronchial and pulmonary
regions altogether. This dose is comparable to the high
(200 μg) dose from the IT experiments.
Aerosol droplet size varied (Figure S1) during the
exposure to F-MWCNTs in water. Initially, approxi-
mately 80% of the particle mass impacted at the first
stage [effective cutoff diameter (ECD) = 4.66 μm]. Later,
particle mass evened out, depositing at e20% at each
of the stages. For the latter case, the highest deposi-
tion occurred primarily at stages 14, corresponding
to ECDs ranging from 4.66 to 1.62 μm. TEM of the
nebulized MWCNTs showed a range of MWCNT
sizes and morphologies. Aerosolized MWCNTs were a
mixture of individual and agglomerated nanotubes,
although the latter appeared most common in point-
to-plane electrostatic precipitator (ESP) samples
(Figure 2A) due to the sampling method.
Aerosol Characterization: MWCNTs in DM. Field blanks
were clean for all exposures involving MWCNTs sus-
pended in DM. Operating at 10 L/min, with a 1 mg/mL
suspension of O-, P-, or F-MWCTs in DM, the Heart
nebulizer output was approximately 70 μL/min (nearly
double that of F-MWCNTs in water, 38 μL/min), and
the estimated MWCNT aerosol concentration was
Figure 1. SEM images of all MWCNT formulations. From left to right (AC): O-, P-, and F-MWCNTs. Outer diameter: 2030 nm;
inner diameter: 510 nm; length: 1030 μm.
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approximately 70 mg/m3. This makes sense because
the DM has a lower surface tension than water as a
result of the added pulmonary surfactant, disaturated-
phosphatidylcholine. Water has a surface tension of
about 7077 dyn/cm, and the pulmonary surfactant
surface tension is about 25 dyn/cm. The latter is
enough to enable droplet formation during nebuliza-
tion (as with water), but surfactant will not aggregate
like water and will instead spread out over a surface.
We believe this, along with a potentially lower visco-
sity21 for DM versus water, enabled the faster output
rate of suspended MWCNTs in DM versus water.
Gravimetric analysis of cascade impactor samples
could not be used to confirm MWCNT concentrations
in the aerosols due to the significant mass added by
the DM. However, exposure system output and nose-
port sampling filters were black (as with the F-MWCNTs
in water exposure), indicating the presence of MWCNTs
in the aerosol. Additionally, a suspension ofMWCNTs in
DM produced more normal aerosol size distributions
(Figure S2) [not present with F-MWCNTs in water
(Figure S1)], allowing calculation of the aerosol droplet
mass median aerodynamic diameter (MMAD) and
geometric standard deviation (GSD) using a modified
spreadsheet designed for eight-stage cascade impac-
tor data.22 Data showed that the aerosol droplet size
distribution for nebulizedO- and P-MWCNTs in DMwas
relatively consistent throughout the entire exposure
period (Figure S2A and B, respectively), while that for
F-MWCNTs in DM (Figure S2C) was slightly more vari-
able. Despite this, all three formulations produced
aerosol droplets, with the majority (approximately
6080%) of the mass depositing at stages 13
(ECD= 4.662.15μm, respectively) (Figure S2). MMADs
and GSDs for droplets of O-, P-, and F-MWCNTs were
3.7 ( 2.5, 4.8 ( 2.9, and 3.3 ( 3.1 μm, respectively.
TEM of the nebulized O-, P-, and F-MWCNTs was
impaired because the lower surface tension MWCNT
suspensions in DM did not adhere well to the TEM
substrate grids during point-to-plane ESP sampling.
This was especially true for O- and P-MWCNTs. Overall,
despite the higher nebulizer output, fewer MWCNTs
were collected on TEM grids (Figure 2B). However,
results showed that like F-MWCNTs in water, aeroso-
lized MWCNTs in DM were a mixture of individual and
agglomerated nanotubes (Figure 2). Unlike aerosolized
F-MWCNTs in water, MWCNTs in DM were primarily
observed as singlets or small tangles (Figure 2).
Given the aerosol droplet size range and an average
MWCNT concentration of approximately 70 mg/m3
over the course of the 6 h exposures to O-, P-, or
F-MWCNTs in DM, rats would have inhaled approxi-
mately 3.8 mg of MWCNTs (with a ventilation rate =
0.15 L/min), correlating to deposition (10%)20 of 380 μg
in the tracheobronchial and pulmonary regions alto-
gether. This dose is nearly double the high (200 μg)
dose from the IT experiments.
At least one study23 showed that breathing rate is
variable during inhalation exposures, and despite this,
deposition in the lungs still ranged between 10% and
14% for the aerosols ranging from 0.45 to 4.5 μg. Thus,
the calculated deposited doses for all inhalation
exposures (MWCNTs in DM and F-MWCNTs in water)
appear sound.
Animal Weight. Animal weight was unaffected by
exposure to MWCNTs compared to controls (data
not shown). There was no correlation between weight
change (loss) following instillation and subse-
quent degree of neutrophilia postexposure (data not
shown).
BALF Total Cells. The number of total cells recovered
from BALF was unchanged in MWCNT-treated animals
compared to control animals following IT and inhala-
tion (Figure S3). However, ANOVA model effect tests
did show that, overall, MWCNT formulation and time
postexposure significantly affected total cells recov-
ered from BALF upon IT/inhalation of MWCNTs sus-
pended in DM (Table S1). Inhalation of F-MWCNTs in
Figure 2. TEM Image of aerosolized F-MWCNTs captured by ESP. F-MWCNTs (white arrow) suspended in water (A) or
dispersion media (B) deposited on TEM grids (black arrows) during inhalation exposures.
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water produced no significant changes in BALF total
cells irrespective of time postexposure or deposited
dose.
Considering the exposure method specifically, de-
spite the lower (200 μg) MWCNT dose by IT, the total
number of cells recovered in BALF was significantly
higher than inhalation of MWCNTs suspended in DM
(deposited dose 380 μg) (Table 1). Inhalation of
F-MWCNTs in water (227 μg deposited dose) (M =
205.96) also produced significantly higher total cell
numbers (104) than inhalation of F-MWCNTs in DM
(M = 117.28) (Table 1); however, there was no signifi-
cant difference from 200 μg of instilled F-MWCNTs
(M = 202.93). Higher BALF cell numbers in DM-instilled
sham control animals (Figure S3) relative to those
breathing filtered air suggest that the instillationmeth-
od itself may have produced the increase in total BALF
cells relative to inhalation.
BALF Cell Differentials: Neutrophils. Cell differential data
were upwardly skewed, so square-root transformation
was performed to achieve normal distribution for
ANOVA and post hoc statistical analyses. Testing the
interaction of dose, time, and MWCNT formulation
showed that on day 1 instilled O-MWCNTs produced
the most neutrophilia (Figure 3A). By day 21, the acute
neutrophilia observed initially had resolved in all
MWCNT-instilled animals (Figure 3A, C, and E). Upon
inhalation of MWCNTs (Figure 3B, D, F, and G), no
significant differences in total neutrophils were noted
between filtered-air control and MWCNT-exposed
groups. However, total neutrophils were at least 1
order of magnitude lower when contrasted to re-
sponses post MWCNT IT (200 μg) (Figure 3).
Although particle formulation did not seem to play
an important role with respect to BALF neutrophilia
post-IT, the factors of time (Table S2), MWCNT dose
TABLE 1. Significant Post Hoc Comparisons: BALF Total Cells Post IT and Inhalationa
compared factor(s) group I (A) group II (B) mean difference (A  B) standard error difference (A  B) p-value df LCL UCL
exposure instilled O- inhaled O- in DM 87.19 14.15 CON 6 72.39 157.12
exposure instilled P- inhaled P- in DM 76.17 14.40 CON 6 33.06 119.29
exposure instilled F- inhaled F- in DM 85.65 14.56 CON 6 42.03 129.25
exposure inhaled F- in H2O inhaled F- in DM 88.68 13.98 CON 6 46.82 130.54
a df = degrees of freedom. LCL and UCL = lower confidence limit and upper confidence limit, respectively. O-, P-, F- = original, purified, and functionalized multiwalled carbon
nanotubes, respectively. DM = dispersion media.
Figure 3. Instilled MWCNTs stimulate BALF neutrophilia. Values shown are square-root-transformed numbers of neutrophils
(PMNs) in BALF at days 1 and day 21 postexposure to MWCNTs by instillation with dispersion media (DM) (panels A, C, E),
inhalation with DM (panels B, D, F), or inhalation with water (panel G). Results are from ANOVA considering dose, time, and
particle formulation. “†” indicates difference (p < 0.0001) from all other treatment groups shown in the panel. “*” indicates
difference (p < 0.05) from the DM-exposed control group shown in the panel. “#” indicates difference (p < 0.05) from animals
instilled with 200 μg of P-MWCNTs.
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(Table S2), and their interaction (Table S3) were most
significant. These factors were also significant postin-
halation of MWCNTs in DM (Table S4).
BALF Cell Differentials: Macrophages. Upon IT, the total
number of macrophages (Mj) recovered was unaf-
fected by MWCNT formulation, time postexposure,
and/or dose. However, IT (200 μg MWCNTs) did pro-
duce significantly greater macrophages than inhala-
tion of MWCNTs (380 μg) in DM (Table 2). Contrasting
results postexposure to F-MWCNTs via inhalation in DM,
inhalation in water (227 μg), and IT showed that macro-
phage numbers were highest and on par for the latter
two exposure methods (Table 2).
Effect tests showed that all independent factors
(administration method, time, dose, and particle
formulation) played significant roles with respect to
the (square-root-transformed) number of MWCNT-
laden Mj recovered from BALF (Table S5 and Figure 4).
Macrophages with visible MWCNT inclusions (MWCNT-
positive Mj) were significantly higher on day 1 in
animals instilled with MWCNTs at the 50 or 200 μg
doses (Figure 4A, C, and E). For O-MWCNTs, these in-
creases were also significantly different from the 10 μg
dose (Table S5), and data trends suggest that instilla-
tion of 10 μg of P- or F-MWCNTs (M = 394.42 and
M = 539.96, respectively) may produce slightly more
MWCNT-positive Mj than O-MWCNTs (M = 69.75)
(Figure 4A, C, and E). AlthoughMWCNT-laden Mjwere
still visible at day 21 post-IT, due to variability therewere
no significant differences between MWCNT-instilled
TABLE 2. Significant Post Hoc Comparisons: Square-Root-Transformed Number of Macrophages Post IT Exposure
(Instillation versus Inhalation)a
compared factor group I (A) group II (B) mean difference (A  B) standard error difference (A  B) p-value df LCL UCL
exposure instilled O- inhaled O- in DM 54.22 14.07 0.01 6 12.09 96.34
exposure instilled P- inhaled P- in DM 60.92 14.32 0.001 6 18.05 103.79
exposure instilled F- inhaled F- in DM 67.51 14.48 0.001 6 24.16 110.88
exposure inhaled F- in H2O inhaled F- in DM 88.65 13.90 CON 6 47.03 130.27
a df = degrees of freedom. LCL and UCL = lower confidence limit and upper confidence limit, respectively. O-, P-, F- = original, purified, and functionalized multiwalled carbon
nanotubes, respectively. DM = dispersion media. CON represents “convincing” findings at p < 0.0001.
Figure 4. MWCNT uptake by macrophages (Mj) in the lungs postexposure. Values shown are square-root-transformed
numbers of MWCNT-laden Mj in BALF at days 1 and day 21 postexposure to MWCNTs by instillation with dispersion media
(DM) (panels A, C, E), inhalation with DM (panels B, D, F), or inhalation with water (panel G). Results are from ANOVA
considering dose, time, and particle formulation. “‡ and †” indicate differences (p < 0.0001 and p e 0.05, respectively) from
control groups sacrificed on the same day and shown in the same panel. “§” indicates difference (p < 0.05) from a group
(shown in the same panel) exposed to the same MWCNT formulation, at the same dose, but sacrificed on a different day. “*”
indicates difference (p < 0.01) from groups (shown in different panels) exposed to the same dose of a different MWCNT
formulation (O-MWCNTs, P-MWCNTs), but sacrificed on the same day. Finally, “Ω” indicates difference (p e 0.0001) from
groups (shown in different panels) exposed to the same MWCNT formulation via a different administration method, but
sacrificed on the same day.
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and control animal groups (Figure 4A, C, and E) in the
ANOVAmodel. Further, althoughMj laden with O- and
P-MWCNTs appeared to decrease by approximately half
at the 50 and 200 μg doses, the number of Mj with
F-MWCNT inclusions remained relatively high at day 21
(Figure 4A, C, and E). Indeed, particle-laden Mj were
significantly lower on day 21 for animals given 200 μg of
O- or P-MWCNTs (Table S5) than on day 1. Increases in
the number MWCNT-positive Mj did not correlate to
the numbers of Mj in BALF (data not shown), which
werenot significantly differentwith respect to anyof the
independent factors previously mentioned.
Inhalation of F-MWCNTs in water resulted in a
significantly greater number of Mj with visible inclu-
sions (>85%) at days 1 and 21 compared to the filtered-
air controls (Figure 4G). F-MWCNTs in water also
produced the highest numbers of MWCNT-positive
macrophages in contrast to all other F-MWCNT expo-
sure methods (Figure 4G) with no apparent changes
from day 1 to day 21(Figures 4G and 5).
Inhalation of F-MWCNTs in DM (Figure 4F) pro-
duced significantly more particle-laden Mj in contrast
to inhalation of O- or P-MWCNTs in DM (Figure 4B and
D, respectively), but similar numbers in comparison to
(200 μg) instilled F-MWCNTs (Figure 4E), whereas
inhalation of O- or P-MWCNTs in DM (380 μg) pro-
duced much less Mj with visible inclusions than
(200 μg) instilled O- or P-MWCNTs (Figure 4A and C,
respectively).
Presence of MWCNT-positive Mj was confirmed
by TEM (Figures 68) and bright-field microscopy
(Figures 7 and 8). TEM showed that at day 1 O- (data
not shown) and P-MWCNTswere present inMjphago-
lysosomes, while F-MWCNTs occupied the cytosol
(Figure 6). Unlike O- or P-MWCNTs, F-MWCNTs were
also found protruding from the cell membrane of Mj
(Figure 7).
At day 21, micrographs revealed loss of compart-
mentalization for O- and P-MWCNTs, which appeared
in the cytosol (Figures 6 and 8), and differences in
aggregate morphologies. Whereas O- and P-MWCNTs
appeared in large focal agglomerates within the cyto-
sol (Figure 8B and D), F-MWCNTs were dispersed in
smaller aggregates (Figure 8A and C). Amore complete
discussion of these TEM findings are discussed else-
where (to be submitted for publication), wherein re-
sults were confirmed by 3D tomography.
BALF Supernatant and Blood Assays. BALF supernatant
assays (total protein and LDH) and blood CBCs showed
no significant differences between control and exposed
animals irrespective of MWCNT formulation, adminis-
trationmethod, or time postexposure (data not shown).
Histopathology. At 1 day postexposure, animals in-
stilledwith 200μgofMWCNTexhibited focal centriacinar
Figure 5. Inhaled F-MWCNTs inwater caused heavy and sustainedparticle loading in BALFMj. Cells recovered from the BALF
of filtered-air control animals (A andC) or F-MWCNT-exposed animals (B andD) at days 1 (A, B) and 21 (C, D). Cellswere stained
with Diff Qwik. Panels are bright-field microscopy images of representative cells from rats exposed during a single 6 h time
period. Arrows indicate F-MWCNTs.
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inflammation in regions adjacent to visible particle
agglomerates or particle-laden Mj in the air spaces
(Figure 9).
Nearby blood vessels were affected in only themost
severe instances. Instilled O- and P-MWCNTs produced
obvious particle agglomerates with significant in-
creases in cellularity at day 1 (Figure 10A and C), as
did inhaled F-MWCNTs (Figure 10G). O- and P-MWCNT
IT exposure also produced significantly greater bron-
chiolar inflammation over sham controls (Figure 10A
and C). Although instilled P-MWCNTs were foundmore
frequently, at day 1, to produce stronger particle-
associated inflammation (Figure 9), only instilled
O-MWCNTs produced significantly increased alveolar
and pleural inflammation (Figures 10A and 11) in
contrast to controls. This acute alveolitis was signifi-
cantly greater upon O-MWCNT instillation (Figure 10A)
in contrast to P- or F-MWCNT (Figure 10C and E,
respectively). Similarly, pleural inflammation resulting
from IT of O-MWCNTs (Figure 10A) was also higher
than that produced by P- (Figure 10C) or F-MWCNTs
(Figure 10E). As awhole, O-MWCNTs produced a greater
effect than either instilled P- or F-MWCNTs in the alveoli
(Figure 10A), where severe inflammatory infiltrates
were often observed filling the air spaces (Figures 9C
and 11D), and at the subpleura (Figure 10A), where
moderate influxes of Mj were observed (Figure 11C).
Marked numbers of cells in the bronchiolar region
and/or terminal bronchiolealveolar duct junction
(Figure 11D) also contributed to a greater overall in-
flammatory response to O-MWCNTs on day 1. ANOVA
results showed that exposure to F-MWCNTs by IT and
inhalation in DMdid not produce statistically significant
inflammation in contrast to controls at day 1 (Figure 10E
and F). Inhaled F-MWCNTs (227 μg) suspended in water
did produce significantly more particle-associated in-
flammation versus filtered-air controls (Figure 10G) and
versus (380 μg) inhaled F-MWCNTs in DM (Figures 10F),
but not more than (200 μg) instilled F-MWCNTs
(Figure 10E). Due to the low dose rate inhalation
exposures (with an inherent lack of bolus MWCNT
deposition in tissues), the most severe particle-
associated inflammation in animals that inhaled
MWCNTs (suspended in DM or water) (Figure 12) was
Figure 6. Different MWCNTs are located in different cellular compartments. Interior of alveolar Mj recovered from BALF at
1 day postexposure to F-MWCNTs (A) and P-MWCNTs (B) by intratracheal instillation. P-MWCNTs at 21 days postexposure are
shown on the right (C). Panels are TEM images of representative cells from rats exposed to a one-time bolus dose (200 μg) of
MWCNTs suspended in dispersion media.
Figure 7. F-MWCNT uptake by Mj. Cells recovered from BALF at 1 day postexposure to F-MWCNTs by intratracheal
instillation. Bright-field image (A) of an alveolar macrophage with protruding F-MWCNTs (linear, black particles), verified by
TEM (B), suggests cellular entry by penetration. BAL cells were stainedwithDiffQwik for bright-fieldmicroscopy. Black arrows
point to F-MWCNT.
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a score of 1 (Figure 10), corresponding to little/no
increase in vicinal cellularity (Supporting Figures S4 and
S6). This was much lower than that in MWCNT-instilled
animals, which produced scores of e3 (Figure 9).
By day 21, all MWCNT-exposed animals had a mild
to moderate level of inflammation with no significant
differences from control animals. Instilled F-MWCNTs
(M = 1.83) caused less bronchiolitis than O- and
P-MWCNTs (M = 2.75 and 2.88, respectively) and less
pleural inflammation (M = 0.83) than O- and P-MWCNTs
(M = 1.83 and 1.88, respectively) (Table S6). Instilled
F-MWCNTs (M = 2.17) also produced significantly less
perivascular inflammation than O-MWCNTs (M = 2.67),
but not P-MWCNTs (M = 2.50) (Table S6). Additionally,
instilledMWCNTs produced significantlymore (Table S7)
alveolar, bronchiolar, pleural, and/or perivascular in-
flammation than inhaled MWCNTs.
Analysis of AB/PAS and Picrosirius red slides re-
vealed no differences between control and MWCNT-
treated animals, indicating no increases in mucosal
production or fibrotic changes, respectively, regardless
of MWCNT formulation, time postinstillation, or meth-
od of administration (data not shown). Although the
possibility of frustrated phagocytosis was examined,
and evidence of macrophage aggregates in BALF
(Figure 8) and lung tissues (Figures 9BD and 11C,D)
was noted, the MWCNT formulations in DM were
generally e1 μm in length. This is evident especially
in cells recovered from BALF (Figures 58). Because
the threshold length at which frustrated phagocytosis
has been shown to occur is g10 μm in vivo,24 we
believe that particle-associated frustrated phagocyto-
sis, if present, was primarily isolated to regions of the
lungs where large particle agglomerates were present
(terminal bronchiolealveolar duct junction, bronch-
ioles, Figures 9 and 11). By day 21 postexposure, given
the lack of PMNs, fibrotic changes, and granulomas, it is
likely the larger particle agglomerates were already
gone and that the remaining MWCNTs were of a small
enough size that they were readily taken up by macro-
phages so as to not activate inflammatory responses.
Programmed Thermal Analysis. Inhaled MWCNTs in
DM were not tested due to limited resources and
unidentified use of DM-suspended MWCNTs for prac-
tical purposes. Although instilled MWCNTs were also
suspended in DM, the known dose delivered to the
Figure 8. Morphology of F-MWCNTsdiffers fromO-MWCNTs in cells at 21 days postinstillation.Mj recovered fromBALF at 21
days postexposure to F-MWCNTs (A and C) and O-MWCNTs (B and D) by intratracheal instillation. Top panels are bright-field
microscopy images of representative cells from rats exposed to a one-time bolus dose (200 μg) of MWCNTs. Results are
mirrored in TEM images (bottom panels). F-MWCNTs appear as multiple dispersed aggregates within the Mj (black arrows),
while the O-MWCNTs are clustered within a much larger and single aggregate (white arrow). BAL cells were stained with Diff
Qwik for bright-field microscopy.
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Figure 10. MWCNTs produced variable histopathology. Results from semiquantitative scoring are shown for O-MWCNTs
(A, B), P-MWCNTs (C, D), and F-MWCNTs (EG) for day 1 postexposure. Results are from ANOVA considering dose, particle
formulation, and exposure method. “‡ and †” indicate differences (p < 0.0001 and p e 0.05, respectively) from control groups
sacrificed on the sameday and shown in the samepanel. “§” indicates difference (p< 0.05) from agroup (shown in the samepanel)
exposed to the same MWCNT formulation, at the same dose, but sacrificed on a different day. “*” indicates difference
(p < 0.01) from groups (shown in different panels) exposed to the same dose of a different MWCNT formulation (F-MWCNTs,
P-MWCNTs), but sacrificed on the sameday. “*” indicates difference (p< 0.0001) fromgroups (shown in different panel) exposed to
the same dose of a differentMWCNT formulation (F-MWCNTs), but sacrificed on the same day. “Ω” indicates difference (pe 0.001)
fromgroups (shown in different panels) exposed to the sameMWCNT formulation via all other administrationmethods (inhalation
and instillation), but sacrificed on the same day. Finally “R” indicates difference (pe 0.05) from groups (shown in different panels)
exposed to thesameMWCNTformulationviadifferentadministrationmethods (inhalationwithDM),but sacrificedon thesameday.
Figure 9. Instilled MWCNTs produced particle-associated inflammation in the lung parenchyma at day 1. Histopathological
findings from exposure to DM (A), P-MWCNTs (B), O-MWCNTs (C), and F-MWCNTs (D). Panels are bright-field microscopy
images of the most severe responses observed in lung tissues from rats given a single 200 μg dose of MWCNTs or 250 μL of
DM. Tissues were stained with H & E. Solid arrow = MWCNTs, and broken arrow = inflammatory polymorphonuclear cell.
Scale bar (25 μm) applies to all panels.
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lungs made conclusions regarding MWCNT retention/
clearance possible. Spiked tissue recoveries of hydro-
phobic (O- and P-) MWCNTs were equivalent (87.6%),
but hydrophilic F-MWCNT recovery was lower (30.12%).
Previous research showed that O- and P-MWCNTs be-
haved the same in terms of recovery and behavior
during PTA.17 Statistical analysis of MWCNT quantities
measured in the right caudal lung lobe by PTA at
postexposure days 1 and 21 revealed no significant
differences due to time, particle formulation, or admin-
istration method (IT vs inhalation with water); how-
ever, there was a data trend suggesting that instilled
F-MWCNTs may be retained in the lungs to a higher
degree than either O- or P-MWCNTs (Figure 12A). The
instilled 200 μg dose of F-MWCNTs was associated with
greater variability in retention than the 50 μg dose or
that received by inhalation (Figure 12B). The mass of
inhaled F-MWCNTs recovered by PTA more closely
matched the mass recovered from the 50 μg instillation
(IT) group andnot the 200μg ITgroupasexpectedgiven
the deposited dose estimate of 227 μg. However, there
were no significant differences in retention between
any F-MWCNT-exposed groups (Figure 12B).
Because at least 10% of the instilled MWCNT
mass was still present in the caudal lobes at day 21
(Figure 12), the data confirm a lack of significant
MWCNT clearance from day 1 to 21 despite MWCNT-
positive cells in BALF (Figures 48) and confirmation of
CNTs found in airway cilia (Figure 13).
Effects Due to Dose. The purpose of this study was to
investigate how correlations between (a) MWCNT
dose, (b) particle physicochemical characteristics, and
(c) administration techniques modulate pulmonary
inflammation and cellular injury over time. Results
do suggest a doseresponse effect. BAL cell analyses
showed that 50 μg was the lowest dose at which
Figure 12. Programmed thermal analysis quantification of MWCNTs in lung tissue. (A) Day 1 and 21 time-course data from
animals instilled with O-, P-, or F-MWCNTs. (B) Time-course data from animals exposed to F-MWCNTs by intratracheal
instillation and inhalation.
Figure 11. Instilled O-MWCNTs produced significant inflammation in the lungs at day 1. Histopathological findings of pleural
(A) and (B) bronchiolar inflammation in rats exposed to 250 μL DM or a single 200 μg dose of O-MWCNTs (C and D,
respectively). Panels are bright-field microscopy images of representative responses. Tissues were stained with H & E.
Scale bar is 50 μm in panels A and C and 100 μm in panels B and D.
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significant differences from control could be observed
(Figure 3), whereas the 200 μg dose most consistently
produced acute inflammatory responses (Figure 3).
These doses tested were not sufficient to produce
significant differences in BALF supernatant and blood
CBC assays, which may have been insensitive assay
choices in hindsight. Because of the results observed in
BALF, only tissue samples from animals instilled with
200 μg of MWCNTs were compared to controls. How-
ever, given that a 200 μg dose of O- or P-MWCNTs
produced highly significant particle-associated in-
flammation, and a 50 μg instillation of MWCNTs was
sufficient to produce neutrophilia and significant
MWCNT-positive macrophages (in contrast to control),
it is possible we would have seen acute inflammation
by histopathology in animals given 50 μg of O-
or P-MWCNTs too. Overall, histopathology findings
echoed those from BALF differentials: the 200 μg dose
produced significant inflammation in contrast to sham
controls, and O-MWCNTs often produced greater
inflammatory responses than P- and F-MWCNTs
(Figures 3 and 10A, Table 2).
Role of Physicochemical Particle Characteristics. Physico-
chemical characteristics and exposure methodology
appeared to play important roles in particle retention
and/or macrophage function, BALF neutrophilia, and
histopathology. Most statistically significant results
found at postexposure day 1 resolved by day 21, inti-
mating that inflammatory responses due to MWCNTs
were predominantly transient. Although instillation of
200 μg of O-, P-, or F-MWCNTs induced neutrophilia at
day 1 postexposure, responses to O-MWCNTs were
significantly higher than those to P- and F-MWCNTs
(Figure 3A, Table S1). By day 21 however, neutrophilia
was resolved in all MWCNT-exposed animals (Figure 3).
A significant percentage of Mj-containing visible in-
clusions were also found in BALF, at day 1, in animals
instilled with 50 or 200 μg of MWCNTs (Figure 4A, C,
and E, Table S5). However, at day 21, (1) only instilled
F-MWCNTs (not instilled O- or P-MWCNTs) produced
significant particle-laden Mj (Figure 4E); (2) inhaled
F-MWCNTs in DMproduced significantlymoreMWCNT-
positive Mj than inhaled O- and P-MWCNTs in DM
(Figure 4F); and (3) inhaled F-MWCNTs in water showed
no difference from day 1 (Figure 4G). This could be due
to a slightly higher degree of retention, which is sug-
gested by the trend in Figure 12A at day 21 and/or a
difference in their ability to be taken up by macro-
phages. Semiquantitative histopathological assessment
showed that at day 1 O-MWCNTs produced the greatest
overall inflammatory effects in contrast to P-and
F-MWCNTs (Figure 10) and the most statistically signifi-
cant differences between control and 200 μg instilled
animals (Figure 10). Although 200 μg was sufficient to
produce significant, acute, particle-associated inflam-
mation, only O-MWCNT exposure resulted in statistically
marked alveolar, bronchiolar, and pleural inflammation
at day 1 as well (Figure 10). As a whole, results suggest
that with the given exposure methods and measured
biological end points instilled MWCNTs produced only
acute inflammation. However, O-MWCNTs produced
the most potent inflammatory responses (Figures 3,
10, and 11, Tables S1 and S6), and F-MWCNTs affected
Mj-mediated uptakemost andmay bemore persistent
(Figures 4 and 12B). Although some research suggests a
fibrotic response could occur at later time points,25,26
the results are consistent with findings from other
previously published studies using the same or similar
materials3,2730 showing only transient MWCNT effects
in the lungs.
Potential reasons for the relatively higher potency
of instilled O-MWCNTs and/or greater uptake of
F-MWCNTs (instilled or inhaled) are multifold. Particles
differed by metal content, functionalization, sur-
face area, and size, all of which play roles in particle
uptake, clearance/retention, cell viability, and toxicity.
O-MWCNT instillation may have produced more in-
flammation due to a higher percentage of catalyst
metals (Ni and Fe) by mass. O-MWCNTs had the most
(4.5% Ni, 0.8% Fe) followed by P-MWCNTs (1.8% Ni,
0.1% Fe), and finally F-MWCNTs (negligible Ni and Fe,
0.2% S). This mirrors the degree of inflammatory
responses. Previous studies suggest that higher metal
content may correlate to an increase in oxidative
potential and/or inflammation.3032 Although some
studies with MWCNTs show no differences between
metal-containing and purified formulations,33 catalyst
metals complexed to CNTs behave differently
from each other in acidic (e.g., lung lining) and
neutral environments.34 Depending upon the exposure
Figure 13. SEM images of inhaled F-MWCNTs in ciliated cells along the main airway. White arrows indicate F-MWCNTs.
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parameters [e.g., type ofmetal catalyst, time, suspension
media, CNT storage conditions (light, temperature), and
biological environment], results may vary even between
studies using the same nanomaterials.
Fe is known to generate hydroxyl radicals, promote
intracellular reactive oxygen species, and decrease cell
viability.34,35 Increased Ni has been linked to concomi-
tant increase in NLRP3 inflammasome activation,
which influences inflammation and apoptosis, to pro-
duce significant histopathology31 and decreases in cell
viability32 in MWCNT-instilled mice. Altogether, find-
ings support the hypothesis that Ni and/or Fe content
explain(s) the relative magnitudes of toxic responses
with O-MWCNTs g P-MWCNTs g F-MWCNTs.
Addition of acidic functional groups, as with
F-MWCNTs, causes an overall increase in hydrophilicity,
which is generally linked to easier clearance from
the body and a relative decrease in toxicity. Recent
publications lend credibility to these assump-
tions,18,28,30,32,3638 and at least one study suggests
that toxicity decreases with increased COOH func-
tionalization.29 Research by Sager and colleagues39
suggests this may be due to F-MWCNTs' ability to
prevent phagolysosome permeability, release of lyso-
somal contents into the cytosol, and downstream
activation of the NLRP3 inflammasome. These results
were bolstered by findings32 that show intact and
damaged phagolysosomes in alveolar macrophages
exposed to F-MWCNT and P-MWCNT, respectively,
despite the appearance of greater F-MWCNT uptake.
Although primary size was similar for all MWCNTs
in dry bulk form, and the hydrodynamic size of
F-MWCNTs (234 ( 24 nm) was lower than that of
O- and P-MWCNTs (324 ( 33 and 858 ( 58 nm,
respectively), particles were suspended in DM for IT.
The DMacts as a lung fluidmimic, providing equivalent
dispersion of engineered nanomaterials to BALF,
and stabilizes hydrophobic particles (like O- and
P-MWCNTs) to decrease clumping and settling; yet,
DM alone avoids added toxicity. Serum albumin has
been used effectively to provide dispersion and sus-
pension of CNTs.3,18,26,40 Previously, the MWCNTs used
in our study were stabilized by serum albumin (SA) in
phosphate-buffered saline and in 0.9% NaCl.41 Co-
administration of dipalmitoylphosphatidylcholine sig-
nificantly enhanced the stability of O-MWCNTs, but
had no effect on P- and F-MWCNTs. As indicated by
the images presented in Figure 1, long MWCNTs
especially contain bends and kinks. Because the
O- and P-MWCNTs do not contain added functional
groups to sterically hinder agglomeration, formation of
bundles/aggregates and precipitation is more likely in
the absence of DM. Comparison of particles in DM
showed O- and P-MWCNTs were roughly equivalent in
size, but F-MWCNTs were smaller (measured by dy-
namic light scattering) when suspended in ionic media
and bovine SA.41 It is possible that the F-MWCNTs were
preferentially taken up by macrophages due to a
relatively lower agglomeration status, allowing more
contact between dispersed particles and cells and/or
increased uptake via penetration of the cell membrane
(Figure 7)4244 or other vesicle-mediated pro-
cesses.45,46 Indeed, previous studies have shown ag-
glomeration status to be a factor in particle uptake
and retention/clearance.42,47,48 The biomolecular
“coronas”, formed by weak interactions between the
DM, biological milieu, and the F-MWCNTs, are also likely
to be very different from that of O- and P-MWCNTs. This
difference would distinctly affect transport, uptake, and
clearance of these particles as well.40,4952
Effects Due to Administration Method. Although the
higher aerosol output was an initially unintended and
unexpected result, it enabled comparisons of biologi-
cal responses between a 200 μgbolus dose ofMWCNTs
by IT and approximately double that (380 μg) by
inhalation. Given that several previous studies have
contrasted post-IT and -inhalation responses to
MWCNTs administered at equivalent doses, results pre-
sented herein add to the discussion regarding the
effects of dose rate. Intratracheal instillation ofMWCNTs
resulted in greater neutrophilia (Figure 3A, C, and E)
than inhalation (Figure 3B, D, F, and G), while inhalation
resulted in significantly greater MWCNT-positive Mj
(Figure 4G). Although acute histopathology appeared
to be fairly similar between animals exposed to
F-MWCNT by IT and inhalation with water (Figure 10E
and G, respectively), only the latter produced significant
particle-associated inflammation on day 1 in contrast to
respective controls (Figure 10G). Further, only instilled
animals (including sham controls) showed an overall
inflammatory increase (though slight and insignificant)
over time (Figure S7). These results suggest that inhala-
tion of F-MWCNTs can produce lung inflammation and
that exposure by IT, irrespective of the suspension used,
may produce at least some of the inflammatory effects
observed in tissues.
While IT of nanoparticles in animals is much more
controlled than inhalation, ideally with the full dose
being received by the animal it is amuchmore invasive
process than exposing animals to particles through
inhalation. Furthermore, the delivered dose rate of a
given dose as a bolus versus inhalation is different
by orders of magnitude. This likely affects biological
outcome, as here, although the deposited dose esti-
mate was∼227 μg for inhaled F-MWCNTs in water and
∼380 μg for inhaled MWCNTs in DM, neutrophilic
influx was still, on average, an order of magnitude less
than that seen for even the 50 μg instillation-exposed
animals (Figure 3). Despite this, the number of particle-
laden cells was much higher with inhalation than IT at
both postexposure time points (Figure 4). Previous
studies53,54 showed that the immune inflammatory
response is relatively less robust when the body is
exposed to very small particles given at a low/steady
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rate in contrast to a large bolus. In fact, phagocytesmay
even initially fail to actively take up exogenous, smaller
nanoscale particles until internalization is thermo-
dynamically favorable.42 In these cases, pathological
changes are more often seen with continued, chronic
exposures as macrophage phagocytic capacity be-
comes saturated.
F-MWCNT size in water versus DM and resulting
variations in biomolecular coronas may also have
factored into the enhanced uptake of inhaled
F-MWCNTs and the toxicity of instilled F-MWCNTs.
Particles suspended in water were smaller and more
dispersed than those in DM.41 As above, it is possible
this enabled relatively more contact with Mj and/or
resultant uptake of the smaller, more dispersed
(inhaled) F-MWCNTs in water. This is also applicable
to inhaled MWCNTs in DM delivered at a low dose rate
versus bolus MWCNTs delivered by IT.
Phagocytosis alone can occur by several different
mechanisms, at least some of which are affected by
particle size and surface characteristics.42,45 For in-
stance, CNTs are known to enter Mj via diffusion/
penetration through the lipid membrane,25,43,46,55,56
causing a characteristic porcupine-like appearance to
a cell.44 Indeed, this was observed in our study using
both bright-field microscopy and TEM (Figure 7). Re-
search suggests that while long CNT tangles43 and
localized clusters of singlet CNTs42,45 interact with the
cell membrane and become phagocytosed, dispersed
CNTs of <1 μm are most likely to enter the cell through
diffusion43,44 or receptor-mediated endocytosis (RME).
RME occurs with coronated, dispersed CNTs,46 and
singlet CNTs of >1 μm or localized clusters of CNTs of
<1 μm enter cells via receptorligand binding or RME,
respectively.42,45
Whether penetration by CNTs is harmful to the cell
has yet to be determined. Some studies suggest this
type of entry by CNTs has very little effect on cell
viability,44 with at least one study suggesting penetra-
tion is both bidirectional and innocuous under certain
circumstances.57 Other studies suggest cell penetra-
tion may effect decrements in cell viability.43 However,
these discrepancies may be due to myriad differences
in CNT forms, experimental methods, and biological
end points tested. Certainly, results herein suggest the
former is true, as F-MWNCTs produced little if any signs
of toxicity despite being the only MWCNT formulation
observed penetrating the cell membrane.
How and whether CNT location within the Mj
affects cellular functions (e.g., phagocytosis, cell signal-
ing, release of inflammatory mediators) and lung
pathology remains to be elucidated. In an in vitro study
of human monocyte-derived Mj, Porter and col-
leagues43 showed single-walled carbon nanotubes
within lysosomes appeared healthy when viewed with
3D tomography at 2 days postexposure, but at 4 days
postexposure, signs of apoptosis and necrosis were
evident. This could mean that the peak inflammatory
responses were missed in our study by observing
only postexposure days 1 and 21. Hamilton and col-
leagues32 showed that mere uptake of MWCNTs did
not correlate with MWCNT toxicity or NLRP3 activation
in alveolar Mj. Furthermore, NLRP3 activation oc-
curred as a result of phagolysosomal lysis (like Sager
and colleagues,39), suggesting that NLRP3 activation
may not even be necessary for O- and/or P-MWCNTs to
decrease cell viability and increase interleukin (IL)-1β,
an important inflammatory mediator. Their results also
showed differential compartmentalization of MWCNTs
similar to our results.32 Future studies, therefore, should
include a thorough examination of primary Mj post-
exposure to MWCNTs including analyses of phagocytic,
chemotactic, and particle clearance mechanisms, cell
viability, cytoskeletal integrity, major histocompatibility
complex expression, specific protein activity (caspase 1),
and/or cyto/chemo-kine release, e.g., IL-1β and tumor
necrosis factor (TNF)-R.
CONCLUSION
Understanding human health risks associated with
ENMs is particularly challenging because of the wide
range of plausible exposure scenarios. While workers,
consumers, or the general public may potentially be
exposed to nanoparticles through a number of path-
ways (e.g., dermal, ingestion, ocular), inhalation, at least
from an occupational standpoint, is likely to be one of
the most significant routes of exposure. Relating ex-
posure characteristics of airborne particles in experi-
mental studies to those in human exposure settings is
important for establishing exposure/doseresponse
relationships and standards to protect human health.
We acknowledge IT does not represent real-world
exposure conditions or deposition patterns in the lung
that would occur via inhalation. This is due to the fact
that instilled particles in suspension are not subject to
the same physics as airborne particles (impaction,
sedimentation, diffusion), and inhaled CNTs are more
slowly dispersed than an instilled aqueous bolus. Thus,
they are much more likely to reach the distal lung.58
However, the objective of our study was to assess how
different physicochemical particle characteristics and
pulmonary retention of the various MWCNT formula-
tions affect pulmonary toxicity in an attempt to clarify
results from preliminary hazard rankings. This is not
often possible in an inhalation exposure scenario with-
out actual dosimetry measurements, which were, at
the time of the study, difficult without the use of
tagged MWCNTs and/or higher metal content. Label-
ing of MWCNTs for postexposure tracing could affect
interactions within the body (i.e., with large fluorescent
tags) or entail excess cost and increased safety mea-
sures (i.e., with 14C radiolabeling). As such, the ex post
facto PTA data presented lack early time (T) points
(e.g., T0, T < 24 h, and T > 1 < 21) necessary to fully
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understand particle clearance. Additionally, though
exposure to MWCNTs occurred via nebulization ap-
proximating a 5-month occupational exposure, real-
life exposures are more likely to happen with dry bulk
materials at much lower concentrations, as in various
stages of production, packing, or transport of ENMs.
Aside from the high concentrations, the aerosolized
MWCNTs (in water) generated herein appear close to
those encountered under workplace conditions in that
the CNTs occur primarily as tangles with heteroge-
neous sizes and morphologies.59
In the future, subsequent studies may benefit from a
larger sample size and multiple-day inhalation expo-
sures. Collecting biological samples at more time points
and utilizing analytical dosimetry methods such as PTA
could yieldmuchneededdeposition and clearancedata
regarding more “true to life” MWCNT exposures.
Overall, this study has shown that MWCNTs produce
the following: (1) acute, dose-dependent inflammation
at postexposure day 1, which resolved by postexposure
day 21; (2) different inflammatory responses,which likely
correlate to physicochemical characteristics affecting
particle uptake and clearance mechanisms, such
that O-MWCNTs g P-MWNCTs g F-MWCNTs; and (3)
reversed patterns of inflammation and particle uptake
in IT versus inhalation exposures, which may be due in
part to the unnatural presence of bolus particles in the
former versus the latter and subsequently different
defense responses in the lung. Still, these MWCNTs
may create concerns for human health if exposures
occur. Studies show that MWCNTs can persist in the
lung for long periods8,9 and cause toxic responses even
after short, occupationally relevant exposures.11 More
research is needed to elucidate the common mecha-
nisms of MWCNT-induced toxicity associated with
the resulting human and environmental exposures
from the emerging nanotechnology industry. Future
research should expand the efforts described herein
to ensure the safe continuation of MWCNT use in
nanotechnology.
MATERIALS AND METHODS
Bulk MWCNT Preparations. MWCNTs were obtained in powder
form and used as received for the O-MWCNT stock [Cheap
Tubes, Inc., Brattleboro, VT, USA, outer diameter = 2030 nm,
inner diameter = 510 nm, length = 1030 μm, as specified by
themanufacturer and confirmed by SEM (Figure 1)]. Purification
and functionalization of the O-MWCNTs to create P- and
F-MWCNTs, respectively, were carried out using previously
described procedures.6062 Briefly, a microwave-accelerated
reaction system (Mars, CEM, Matthews, NC, USA) fitted with
internal temperature and pressure controls was used. The
reaction chamber, which had an operating range of 0200 C
and 0200 psi, was lined with Teflon PFA. Residual metals
and amorphous carbon were removed from O-MWCNTs via
microwave-induced reaction using dilute nitric acid (1 M) and
saturated ethylenediamine tetra-acetate (EDTA) in CH3COOH at
pH = 4 to produce P-MWCNTs.60,63 The P-MWCNTs were func-
tionalized (F-MWNCTs) by adding them to a reaction chamber
containing 50 mL of a mixture (1:1) of 70% nitric acid and 97%
sulfuric acid. The reaction time was 10 min at a microwave
power of 80% (of the maximal possible 1600 W output) and a
temperature of 140 C. The suspension was diluted with 50 mL
of deionized water, filtered through a 10 mm PTFE membrane,
and vacuum-dried at room temperature.
MWCNTs were characterized using a variety of different
analytical techniques. These included (1) EDS to identify the
elemental composition of the MWCNTs; (2) Fourier transform
infrared spectroscopy (FTIR) measurements in KBr pellets using
a PerkinElmer Spectrum One instrument (Downers Grove, IL,
USA) to provide information regarding molecular structure and
chemical bonding; (3) thermogravimetric analyses (TGA) using
a Q500 TGA from TA Instruments (New Castle, DE, USA) to
determine organic/inorganic content, and (4) BET for determi-
nation of surface area. The specific surface areas of the samples
were measured using a Quantachrome NOVA 3000 series
(model N32-11) high-speed gas sorption analyzer (Boynton
Beach, FL, USA) at 77.40 K. The sample were heated for 3 h
and degassed under vacuum at 300 C prior to surface area
measurement. Scanning electron microscopy using a Genesis
4000 XMS (EDAX Inc., Mahwah, NJ, USA) was also done to image
sample morphology, and zeta-potential measurement of the
MWCNT suspensions was performed using a ZetaSizer Nano-ZS
instrument (Malvern Instruments). Samples were analyzed by
the New Jersey Institute of Technology.18
Animal Protocol. Studies were conducted in accordance with
the Society of Toxicology Guiding Principles in the Use of
Animals in Toxicology. University of California Davis IACUC
(Animal Care and Use Committee) approval was obtained for
all procedures involving rats in this study. Male SD rats (Harlan
Laboratories, Inc., Hayward, CA, USA), 910 weeks of age, were
used because they are calm, easily handled, and very tolerant of
IT and inhalation procedures. At 910 weeks of age, the rats are
similar to human adults, with respect to fully formed lungs and
complete alveolarization, before any signs of senescence.
Upon arrival, animals were weighed and housed in pairs, in
plastic cages (∼20  16  8.25 in.), with narrow, straight-wire,
stainless steel lids; enrichment objects; and CareFRESH absorp-
tive paper bedding. Animals were acclimated for a minimum
of 1 week and given access ad libitum to laboratory rodent diet
(Purina Mills, St Louis, MO, USA) and water throughout the
duration of the experiment. Animal bedding was replaced and
cageswerechangedonaweeklybasis. Aseptic animal roomswere
maintained at approximately 22 C with 12 h light/dark cycles.
After their arrival and initial one-week adaptation period,
animals slated for inhalation studies underwent supplemental
acclimation to the inhalation exposure tubes (Teague Enter-
prises, Woodland, CA, USA) (Figure 14). For a period of 1 to 2
weeks prior to the scheduled exposure, animals were trained to
enter and remain in the exposure tubes until released. Time in
the tube increased up to 6 h at a gradual rate over the training
week(s). This served to decrease/prevent confinement stress
during the actual 6 h inhalation exposure period.
During tube acclimation, measurements of room tempera-
ture and relative humidity (RH) were recorded every 10 min to
ensure the room was kept between 18 and 24 C. Fans were
used for added cooling and air circulation. The exposure tubes
(external portion) were also sprayed with cool water intermit-
tently to prevent heat stress. Care was taken with the loading
and unloading of rats into/out of the tubes to avoid animal
injuries. Animals were allowed to walk freely into the tubes, not
forced into them. Animals were monitored, once securely in the
tubes, for signs of stress and deviations from the desired body
position (tail facing the nose port).
Animal weights were recorded throughout the study. Prior
to exposure, animals were assigned to treatment groups by
weight. This was done in a manner ensuring the mean weight
for all treatment groups, for a particular time point and particle
formulation, was statistically the same. Any animal showing a
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decline in weight during the acclimation period was not used.
Sentinel rats were maintained in the same room and tested to
ensure that experimental animals remained free of pathogens
and/or parasites.
Preparation of Exposure Equipment for Inhalation Exposures. The
nose-only exposure system and the exposure tubes were
sanitized before use by scrubbing with diluted Liqui-Nox and
flushing with water. (Liqui-Nox does not support bacterial
growth and is free-rinsing.) To ensure there was no mold/
mildew growth, the individual system components were
allowed to air-dry for 2448 h in a clean, negative pressure
environment, and once the systemwas reassembled, filtered air
was run through it for a minimum of 8 additional hours. System
cleanliness was determined by viewing outlet filters under
bright-field, EM, and fluorescent microscopy.
Gravimetric Analysis. Gravimetric analysis was conducted in
accordance w/NIOSH Method 5000 for carbon black.64 Though
Method 504065 is currently the recommended method for
measuring airborne carbon nanotubes, we did not have access
to an evolved gas analyzer for measurements of elemental
carbon in the aerosol, specifically. Briefly, before aerosol sam-
pling, each unused filter was inspected for tears, folds, and
other imperfections. A unique identification number was then
assigned to each filter, which was placed in a labeled, static-
dissipative, plastic filter holder (SKC Inc., Eighty Four, PA, USA) to
prevent contamination and damage. Prior toweighing, all filters
were equilibrated for 2448 h at the UC Davis Crocker Nuclear
Lab. All filter weights were obtained using a Cahnmicrobalance
sensitive to (1 μg. The microbalance was calibrated using
National Institute of Standards and Technology standardweights,
and balance checks were performed with control filters after
every five filter weights. Each filter was weighed under carefully
monitored conditions (temperature, RH, gauss level) at least two
times before and after sampling to determine steady pre- and
postweights, respectively. Additional weightmeasurementswere
made as needed until variance was limited to (3 μg.
After sampling, filters were transported to the Crocker Lab
for equilibration and postweighing as described above. Mass
measurements were used to calculate the concentration of
F-MWCNTs in the aerosol.
Preparation of Particle Suspensions for Intratracheal Instillation and
Inhalation Exposures. All dry bulk MWCNTs used for the nanopar-
ticle suspensions were measured using a calibrated analytical
microbalance with a minimum limit of detection equal to
0.003 mg (M5P filter microbalance, Sartorius, Goettingen,
Germany). For IT exposures, MWCNTs were placed in DM
prepared as previously described.66 Proportions were such that
in 1 mL of DM there were 0.399 mL of sterile saline, 0.600 mL of
rat serum albumin (1 mg of RSA powder:1 mL of 0.9% saline),
and 0.001 mL of 1,2-distearoyl-sn-glycero-3-phosphocholine
(DSPC) (10 mg of DSPC powder:1 mL of ethanol).
MWCNT suspensions (10, 50, and 200 μg/250 μL) were
prepared and probe-sonicated as previously described.66
DM served as the sham control instillate. All suspensions were
prepared and loaded into 1 cc Monoject syringes fitted with
1.5-in., 22 gauge, blunt-tippedMonoject needles directly before
instillation. Sonication, syringe loading, and instillation were
choreographed to ensure the highest degree of particle disper-
sion, although even up to 20 h postsonication these media have
been shown to remain well-dispersed in ionic media.41
For inhalation exposures, MWCNTs were dispersed in nano-
pure water or DM in a 240 mL nebulizer at a concentration of
1 mg/mL to generate respirable particles with concentrations
averaging 30 mg/m3 continuously over a 6 h period. Utilization
of a Heart high-output nebulizer (Westmed, Inc., Tucson AZ,
USA) and Krypton-85 source (charge neutralization) allowed
for efficient delivery of single particles rather than large bulk
agglomerates into the nose-only inhalation system (Teague
Enterprises). The suspension was sonicated as above prior to
attaching the nebulizer to the exposure system. The nebulizer
was kept in an ice water bath during the exposure to prevent
evaporation in the MWCNT suspension. Preparations of the
exposure system, MWCNT suspension, and animals were co-
ordinated to maintain the highest degree of particle dispersion
and animal comfort.
Intratracheal Instillations. Two hours prior to instillation, food
was removed from the animal cages. Animals were anesthe-
tized and instilled with 0, 10, 50, or 200 μg of MWCNTs in 250 μL
of DM according to previously published methods.66 For each
MWCNT formulation, a sample size of 48 animals was used, with
6 animals per dose (including shamcontrol) and 24per timepoint.
The tested doses were chosen because they approximate
human occupational exposures to MWCNTs after 1 week,
5 weeks, and 5months in a light work environment. Aerosolized
MWCNTs have been measured at a peak concentration of
approximately 400 μg/m3 and a mass median aerodynamic
diameter of 1.5 μm in a workplace environment.67 A nose-
breathing reference worker with a ventilation rate of 25 L/min
has an alveolar deposition fraction of approximately 10% when
inhaling particles with a 1.5 μm MMAD.68 Humans have an
alveolar epithelium surface area of approximately 102 m2.69
Exposure to 400 μg/m3 MWCNTs produces approximately 5, 24,
and 94 μg MWCNTs/m2 alveolar epithelium after 1 day, 1 week,
and 1 month, respectively. Given the alveolar epithelium of
an SD rat has a surface area of approximately 0.4 m2,69 the 10,
50, and 200 μg MWCNT doses result in 25, 125, and 500 μg
MWCNTs/m2 alveolar epithelium, respectively, approximating
1-week, 5-week, and 5-month human exposures.
Inhalation Exposure and Aerosol Characterization. As with IT, food
was removed from the animal cages 2 h prior to exposure. Each
animal was loaded into an exposure tube, which was then
coupled at an open nose port to the exposure system. Proce-
dureswere similar to acclimation periods, but ratswere exposed
to either nebulized MWCNTs (treated) or filtered air (control)
for a single 6 h period. A diagram of the inhalation system is
provided in Figure 15.
The mass of aerosolized MWCNTs deposited in the lungs
was estimated by multiplying the amount inhaled by the
deposition fraction in the gas exchange/pulmonary (P) and
tracheobronchial (Tb) regions of the respiratory tract. The
fraction of inhaled aerosol deposited in each region of the
respiratory tract is a function of aerosol particle size distribution
for the liquid aerosol. The intended dose to be deposited in the
respiratory tract was calculated by
Deposited Dose ¼ FCTV
where F = fraction deposited in respiratory tract region
(function of particle size) = Pþ Tb = 14%,20 C = aerosol MWCNT
Figure 14. Diagramof (nose-only) inhalation exposure tube.
Image shows a representation of the clear plexiglass tubes
used for the nose-only inhalation exposure study. Once
inside, the rat instinctively moves toward the open nose
port (shown at the right), where it is exposed to MWCNT
aerosol or filtered air if it is a control animal. The tube is
sealed with ametal plunger (shown left), which attaches to a
metal plate and exits through a rubber stopper. The rubber
stopper ensures a firm seal, while the metal plate contacts
the rat's tail and enhances the animal's ability to stay cool
during the exposure period. The exposure tube was de-
signed to minimize thermal stress by providing a heat-
conducting path from the metal butt plate, which keeps
the rodent not only inside the tube but also cool. This design
allows the rodent to self-regulate its body temperature by
changes in blood circulation to its tail, a normal means of
maintaining homeostasis. To ensure that most of the tail-
cooling portion (metal butt plate and plunger) was outside
the tube in the cool room air, the exposure tubes were cut to
a length so that notmore than 1 in. of the plungerwaswithin
the tube. Note: Drawing not to scale.
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concentration (per liter of air) = 38 μg/L air, T = time of aerosol
treatment (minutes), and V = inhaled minute volume of air by
subject = 0.15 L/min or 9L/h for a 300 g rat.
The Heart nebulizer was operated at 10 L/min.70 The output
concentration of liquid aerosol was∼38 μL/L of air with∼12 μL/L
of water vapor. The aerosol was delivered simultaneously to
several individual rats using a version of the multiport exposure
apparatus previously described by Raabe and colleagues.71 The
concentration of the MWCNTs in the nebulizer was 1 mg/mL,
so the expected nebulizer output was 380 μg/min in 10 L of air.
With no diluting air, the expected aerosol MWCNT concentration
was 380 μg/min divided by 10 L/min of air or 38 μg/L (C).
Therefore, the total amount of MWCNTs inhaled in 60 min
by each rat would be ∼340 μg (about 1.1 mg/kg whole body
mass). Assuming that the wet aerosol had a mass median
aerodynamic diameter of about 2 μm (specified by Heart), the
expected deposition would be ∼30 μg/h (8%) in the gas
exchange/pulmonary region of the lung (P); ∼20 μg/h (6%) in
the tracheobronchial region (Tb); and∼170μg (50%) in the head.
Approximately 35% of the inhaled aerosol was expected to be
exhaled.20
Aerosolized MWCNTs were characterized by mass, size, and
morphology using gravimetric filter analysis, an inertial cascade
impactor, and TEM, respectively. Sampling heads were coupled
to the exposure chamber by attaching the sampler inlets to
unused exposure ports. Each cascade impactor (CI)72 was fitted
with eight 25 mm filters (1/stage). Individual samplers were
connected to Universal XR pumps (SKC, Inc., Fullerton, CA, USA)
with Tygon tubing. Air flow through the sampling assembly was
set at 1 L/min. Sampling was performed concurrent to the
exposure period with samplers placed in unused exposure
ports. Field blanks were prepared and handled according to
NIOSH Manual of Analytical Methods recommendations.
CI filter samples were taken to determine the aerodynamic
size distribution of the MWCNT aerosol droplets. Seven-stage
Mercer-type impactors with effective cutoff diameters ranging
from 4.5 to 0.33 μm were used.72 Finally, ESP (In-Tox, Moriarty,
NM, USA) samples were taken on Ultrathin Carbon TEM grids
(Ted Pella Inc., Redding, CA, USA). These grab samples provided
a snapshot of F-MWCNTs as they existed in the aerosol. Sam-
pling timeswere 10min for CI samplers and 5 s for ESP samplers.
All gravimetric filter analyses were completed at the UC Davis
Crocker Nuclear Laboratory. TEM analysis of ESP samples was
completed by the Evans Laboratory, Department of Molecular
and Cellular Biology, University of California, Davis, as previously
described.73
Collection and Analysis of Biological Samples. At 1 or 21 days
postexposure, animals were euthanized with an intraperitoneal
injection of beuthanasia-D 7.5 mL/kg bodyweight followed by
exsanguination. Collection of biological samples was completed
as previously described.66 Blood was sent to the UC Davis
Comparative Pathology Laboratory for CBC analysis. BALF
supernatant was collected for same-day protein and LDH
analyses, which were performed using kits from Thermo Scien-
tific (Rockford, IL, USA) and Sigma-Aldrich (St. Louis, MO, USA),
respectively. BALF cells were kept for determination of total cell
numbers and cell viability with a hemocytometer and Trypan
Blue exclusion dye, respectively. Total cell number, cell differ-
entials, and particle uptake/retention (i.e., visible MWCNT inclu-
sions in Mj) were determined by bright-field microscopy,
counting a minimum of 500 cells from a 100 mL cytospin slide
stained with Diff Qwik (Dade Behring Inc., Newark, DE, USA).
Blind analysis was completed by two observers to ensure
minimal observer bias. After total cell numbers had been deter-
mined, remaining cells were centrifuged as previously de-
scribed and resuspended in agarose for TEM analysis.66
In addition to blood and BALF, histological samples were
collected from each animal. Each right lobe was frozen at
80 C in a separate NUNC cryovial for PTA and/or other future
histological analysis. The left lung was fixed hydrostatically
(30 cm) using 4% paraformaldehyde, microdissected, dehy-
drated in a series of graded ethanol, embedded in paraffin,
and sectioned to 5 μm with a microtome (HM 355, Microm,
Walldorf, Germany).66 Lung sections were placed on slides
and stained for analysis of (1) cellular infiltrates and epithelial
abnormalities, (2) changes in mucosal production, and (3)
collagenous fibrotic changes. These biological end points were
observed using hematoxylin and eosin stains (H & E) (Harris
hematoxylin and eosin Y stain), Alcian Blue/periodic acid
Schiff stain (AB/PAS), and Picrosirius Red stain from American
MasterTech, Inc. (Lodi, CA, USA).
A semiquantitative scoring method was used to distin-
guish the degree of alveolar, bronchiolar, perivascular, particle-
associated, and pleural inflammation in the H & E-stained
tissue sections.66 Briefly, before scoring began, an initial blind,
qualitative assessment was done to determine the range of
responses. Then, to minimize observer scoring subjectivity, a
scoring rubric was made with categorical definitions and pic-
torial guidelines (Figures S4S6) of the ordinal scores (03)
roughly corresponding to no, minimal, moderate, and marked
inflammation, respectively. Blind semiquantitative histological
assessment of all samples was then performed in close
Figure 15. Diagram of the nebulization system. Image shows a representation of the nose-only inhalation exposure
apparatus. Inlet air lines direct filtered air into the Heart nebulizer containing the MWCNT suspension. Aerosolized MWCNTs
flow past the Krypton-85 source and into the inhalation chamber for the animal exposures. Vacuum lines pull air from the
chamber through a heated outlet air filter before exiting the apparatus. Flowmeters attached to the inlet and outlet air lines
and a magnehelic help to ensure balanced flow of air through the system. There are a total of 72 ports (36 on each side) that
can be used for animal exposures and aerosol sampling or sealed off entirely. Note: Drawing not to scale.
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succession to control for scoring variability. A qualitative assess-
ment of AB/PAS- and Picrosirius Red stained-slides was also
completed to determine hyperplasia of mucus-secreting
goblet cells in the airways and/or changes in the types of
mucosubstances being secreted and the presence of fibrotic
lesions, respectively.
Transmission Electron Microscopy and Scanning Electron Microscopy.
Ultrathin sections of resin-embedded Mj were prepared as
previously described73 andwere examined on a JEOL JEM-2100-
FEG transmission electron microscope (JEOL, Japan) operating
at 200 keV. Micrographs were recorded using a 4096  4096
pixel Tietz CCD camera (TVIPS, Germany).
Lungs from animals exposed toMWCNTs by inhalation were
fixed with Karnovsky's fixative (0.9% glutaraldehyde/0.7% par-
aformaldehyde in cacodylate buffer, adjusted to pH 7.4, and
330mOsmol/kg H2O) for 1 h at 30 cmof pressure. The fixed right
middle lobe was then isolated and glued to a 22 mm2 coverslip
(Corning Life Sciences, Lowell, MA, USA) with Nexaband tissue
adhesive (Abbott Animal Health, North Chicago, IL, USA). The
lobe was dissected to expose the airways from the interlobar
bronchus to the terminal bronchioles. The samples were then
(1) rinsed with 0.1 M sodium phosphate buffer to remove
fixative; (2) dehydrated in graduating increments of ethanol
(EtOH) for 15 min/step with three changes of 95% EtOH and
three changes of 100% EtOH; and (3) further processed as
described previously.74 Samples were mounted on aluminum
stubs using double-sticky carbon tabs and sputter coated with
gold using a PELCO SC-7 auto sputter coater (Ted Pella). They
were then viewed on an FEI XL-30 TMP scanning electron mi-
croscope (FEI, Hillsboro, OR, USA), and images were acquired.75
Airways were imaged at bifurcations. Confirmation of the
presence of MWCNTs in cilia was done by energy-dispersive
X-ray spectroscopy. Work was performed on a Phillips FEG SEM
at the Advanced Materials Characterization and Testing Lab
(AMCaT) at UC Davis.
Programmed Thermal Analysis. PTA17 was used to quantify
MWCNT clearance/retention on right caudal lung lobes from
control and MWCNT-exposed animals. Particle loading was
examined in the caudal lobe because it is the largest lobe and
it represents the long airway path of the lung. Previous work
suggests that much of the instilled/inhaled particles are depos-
ited in the right caudal lobe.23,66 Deposition in the right caudal
lobe is also less likely than the other right lobes to be signifi-
cantly different between the two exposure methods76,77 given
equivalent doses, particle formulations, and animals used. A
two-step CNT extraction method followed by PTA allowed for
highly sensitive and precise detection of MWCNTs with a
method detection limit of approximately 700 ng. Complete
details for detecting MWCNTs in digested lung tissues are
described elsewhere.10 Briefly, lung tissue samples were mixed
with Solvable at 60 C for 24 h followed by treatment with
proteinase K at 56 C for 24 h. Samples were washed after each
step to remove interfering carbon on the CNT surface. Samples
were then loaded onto prefired quartz-fiber filters (Pall Tissu-
quartz filters, 2500 QAT-UP) and analyzed using PTA. Solvable
consists of sodium hydroxide, and precautions should be taken
when handling it.
The NIOSH 5040 method outlined for CNTs in air78 was not
applicable to heterogeneous samples such as CNTs extracted
from rat lung tissue because of the misinterpretation of the
transmission analysis.17 As a result, a modified version of this,
applicable to complex heterogeneous matrices such as rat lung
tissue, was used.10,17
Statistical Analysis. Graphical data are presented as mean (
standard error of the mean whenever possible. Descriptive
statistics from effect tests are presented in the text or tables
and include groupmeans (M), degrees of freedom (df), p-values
(p), and/or confidence intervals. JMP 10.0.0 statistical software
(Cary, NC, USA) was used to perform analysis of variance
(ANOVA) and post hoc Tukey's range tests. Tables show some
values obtained from Tukey's HSD Multiple Comparisons;
here p-values were rounded up to 0.05, 0.01, or 0.001. Rat
weights, histopathology scores, total cells, percent PMNs,
LDH, total protein, percent particle-laden cells, and CBCs were
analyzed. The analyses considered the main effects of and
interactions between the factors, dose, time, particle formula-
tion, and/or administration method. The data were first ana-
lyzed for deviations from the assumptions of ANOVA, and
outliers were identified viabox plots. Normal distribution results
were confirmed by QQ plots and Shapiro-Wilk tests (p > 0.05
and/orWg 95), which are useful for small sample sizes (n < 50),
and homoscedasticity was confirmedwith Levene and Bartlett's
tests. In cases when ANOVA was appropriate, the model in-
cluded all data for a given biological end point to decrease error
caused by multiple separate analyses. For all analyses, a p-value
of 0.05 was used to determine significance. Although pathology
scores were ordinal, these data were treated as continuous after
confirming ANOVA assumptions were met. ANOVA instead
of categorical analyses was run on histopathology scores to
(1) enable tests of interactions between independent variables
and (2) control for type I and II errors, which can be incurred by
multiple separate nonparametric analyses.
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